中文

← All funding rounds

Rivercell

EuropeBiology data and toolsParis, FranceFounded 2025Private

Website · rivercell.ai ↗

Generates time-resolved, multimodal single-cell data on how human cells respond to drugs and genetic changes, on its own platform and automated wet lab, to train an 'AI virtual cell' model that predicts those responses.

Disclosed total$25M
Rounds on record1
Latest round$25MSeed · 2026-10-07
Last stated valuationNone stated
Investors named4
Research on recordNone yet

Money and evidence

Moneyeach round in US dollars; ≈ converted at its date$25M
Closed round

No research by this company is on the record yet.

Rounds and research, on one timeline

  1. 2026-10-07Seed
    Round

    $25M

    For: scale its data-generation platform and automated wet lab in Paris, and launch its AI Virtual Cell programme

    Data generationAutomated labModels and platform

    The release calls the lead HV, the firm also known as HV Capital. It also mentions angels from Twist Bioscience, DNA Script, Agilent and Abivax/Ipsen, none named.

    Lead · HV CapitalHCVCAlvenBpifrance Digital Venture

    On the deal: Maxi Pethö-Schramm (Principal; spoke for the firm in the announcement, HV Capital)

    Announced by the company · businesswire.com ↗On the timeline →

Research entries are the timeline's graded entries that name this company. A level grades one claim, not the company, and a blank can mean the record has not caught up rather than that nothing was published.

See these rounds in the table →

Its investors also backed

Other companies on this page whose rounds name the same investor.